Abstract:The transforming growth factor receptor III (TβRIII) is commonly recognized as a co-receptor that promotes the binding of TGFβ family ligands to type I and type II receptors. Within the immune system, TβRIII regulates T cell development in the thymus and is differentially expressed through activation; however, its function in mature T cells is unclear. To begin addressing this question, we developed a conditional knock-out mouse with restricted TβRIII deletion in mature T cells, necessary because genomic deletion of TβRIII results in perinatal mortality. We determined that TβRIII null mice developed more severe autoimmune central nervous neuroinflammatory disease after immunization with myelin oligodendrocyte peptide (MOG 35-55 ) than wild-type littermates. The increase in disease severity in TβRIII null mice was associated with expanded numbers of CNS infiltrating IFNγ + CD4 + T cells and cells that co-express both IFNγ and IL-17 (IFNγ + /IL-17 + ), but not IL-17 alone expressing CD4 T cells compared to Tgfbr3 fl/fl wild-type controls. This led us to speculate that TβRIII may be involved in regulating conversion of encephalitogenic Th17 to Th1. To directly address this, we generated encephalitogenic Th17 and Th1 cells from wild type and TβRIII null mice for passive transfer of EAE into naïve mice. Remarkably, Th17 encephalitogenic T cells from TβRIII null induced EAE of much greater severity and earlier in onset than those from wild-type mice. The severity of EAE induced by encephalitogenic wild-type and Tgfbr3 fl/fl .dLcKCre Th1 cells were similar. Moreover, in vitro restimulation of in vivo primed Tgfbr3 fl/fl .dLcKCre T cells, under Th17 but not Th1 polarizing conditions, resulted in a significant increase of IFNγ + T cells. Altogether, our data indicate that TβRIII is a coreceptor that functions as a key checkpoint in controlling the pathogenicity of autoreactive T cells in neuroinflammation probably through regulating plasticity of Th17 T cells into pathogenic Th1 cells. Importantly, this is the first demonstration that TβRIII has an intrinsic role in T cells.

BRD4 expression in microglia supports recruitment of T cells into the CNS and exacerbates EAE

CD22 blockade aggravates EAE and its role in microglia polarization

STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE (BA4P.140)

Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation

Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE

Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner

Parenchymal Microglia of Naı̈ve Adult C57BL/6J Mice Express High Levels of B7.1, B7.2, and MHC Class II

Nr4a1 Plays a Crucial Modulatory Role in Th1/Th17 Cell Responses and CNS Autoimmunity

IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier

A novel PROTAC molecule dBET1 alleviates pathogenesis of experimental autoimmune encephalomyelitis in mice by degrading BRD4

Role of CD4 T Cell in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis

Microglia and Dendritic Cells as a Source of IL-6 in a Mouse Model of Multiple Sclerosis

Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis

Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood–brain barrier and blood–cerebrospinal fluid barrier

BACE1: a novel player in the pathogenesis of Th17 cells in EAE

Th17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis

MOG-Specific T Cells Lead to Spontaneous EAE with Multilocular B Cell Infiltration in the GF-IL23 Model

Transcription factor T-bet drives the pathogenesis of TH17-mediated neuroinflammation

[Myeloid-Derived Gr-1⁺ CD11b⁺ Suppressor Cells Are Involved in Immunoregulation of Experimental Autoimmune Encephalomyelitis].

CRL4b Inhibition Ameliorates Experimental Autoimmune Encephalomyelitis Progression

STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE